Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

Béïque, Jean-Claude, Imad, Mays, Mladenovic, Ljiljana, Gingrich, Jay A., Andrade, Rodrigo·2007·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.0700436104

Cited by (229)

Items 101–200 of 229

  1. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders
    Andreas B. Wulff, Charles David Nichols, Scott M. Thompson · 2023 · Neuropharmacology
  2. Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
    Adam Wojtas, Monika Herian, Mateusz Skawski, Małgorzata Katarzyna Sobocińska, Alejandro González-Marín, Karolina Noworyta, Krystyna Gołembiowska · 2020 · Neurotoxicity Research
  3. Serotonin, via HTR2 Receptors, Excites Neurons in a Cortical-like Premotor Nucleus Necessary for Song Learning and Production
    William E. Wood, Peter V. Lovell, Claudio V. Mello, David J. Perkel · 2011 · Journal of Neuroscience
  4. Serotonergic neuromodulation of synaptic plasticity
    Higa, Guilherme Shigueto Vilar, Viana, Felipe José Costa, Francis-Oliveira, José, Cruvinel, Emily, Franchin, Thainá Soares, Marcourakis, Tania, Ulrich, Henning, De Pasquale, Roberto · 2024 · Neuropharmacology
  5. Preclinical models of antipsychotic drug action
    José L. Moreno, Javier González‐Maeso · 2013 · The International Journal of Neuropsychopharmacology
  6. Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice
    José L. Moreno, Terrell D. Holloway, Adrienne Umali, Vinayak Rayannavar, Stuart C. Sealfon, Javier González‐Maeso · 2012 · Psychopharmacology
  7. A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
    Blerida Banushi, Vince Polito · 2023 · Biology
  8. Visinin-Like Neuronal Calcium Sensor Proteins Regulate the Slow Calcium-Activated Afterhyperpolarizing Current in the Rat Cerebral Cortex
    Claudio A. Villalobos, Rodrigo Andrade · 2010 · Journal of Neuroscience
  9. Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz
    Dhwanil A. Dalwadi, Seongcheol Kim, Shahnawaz M. Amdani, Zhenglan Chen, Renqi Huang, John A. Schetz · 2016 · Pharmacological Research
  10. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
    Karolina Noworyta, Katarzyna Kamińska, Grzegorz Kreiner, Zofia Rogóż, Krystyna Gołembiowska · 2016 · Neurotoxicity Research
  11. Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases
    Izabela Szpręgiel, Agnieszka Bysiek · 2024 · Pharmacological Reports
  12. 5-HT2A and 5-HT2C receptor stimulation are differentially involved in the cortical dopamine efflux—Studied in 5-HT2A and 5-HT2C genetic mutant mice
    Mei Huang, Jin Dai, Herbert Y. Meltzer · 2010 · European Journal of Pharmacology
  13. Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study
    Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska · 2023 · International Journal of Molecular Sciences
  14. Serotonin and schizophrenia
    Boris B. Quednow, Mark A. Geyer, Adam L. Halberstadt · 2020 · Handbook of behavioral neuroscience
  15. Enhanced TARP-γ8-PSD-95 coupling in excitatory neurons contributes to the rapid antidepressant-like action of ketamine in male mice
    Shi-Ge Xue, Jin‐Gang He, Ling-Li Lu, Shi-Jie Song, Meimei Chen, Fang Wang, Jianguo Chen · 2023 · Nature Communications
  16. Serotonin–Dopamine Interaction: Experimental Evidence and Therapeutic Relevance
    2008 · Progress in brain research
  17. 5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
    Kazuhito Nakao, Mahendra Singh, Kiran Sapkota, Andrew Fitzgerald, John J. Hablitz, Kazu Nakazawa · 2022 · Translational Psychiatry
  18. A Characterization of the Manduca sexta Serotonin Receptors in the Context of Olfactory Neuromodulation
    Andrew M. Dacks, Vincenzina Reale, Yeli Pi, Wujie Zhang, Joel B. Dacks, Alan J. Nighorn, Peter D. Evans · 2013 · PLoS ONE
  19. Repeated Cocaine Administration Decreases 5-HT2A Receptor-Mediated Serotonergic Enhancement of Synaptic Activity in Rat Medial Prefrontal Cortex
    Chiung‐Chun Huang, Ying‐Ching Liang, Cheng-Che Lee, Mei-Ying Wu, Kuei‐Sen Hsu · 2009 · Neuropsychopharmacology
  20. Temporal derivative computation in the dorsal raphe network revealed by an experimentally driven augmented integrate-and-fire modeling framework
    Emerson F. Harkin, Michael B. Lynn, Alexandre Payeur, Jean-François Boucher, Léa Caya-Bissonnette, Dominic Cyr, Chloe A. Stewart, André Longtin, Richard Naud, Jean-Claude Béïque · 2023 · eLife
  21. The altered state of consciousness induced by Δ9-THC
    Conor H. Murray, Bhargav Srinivasa Desikan · 2022 · Consciousness and Cognition
  22. Role of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and psychedelics in the treatment of major depressive disorder: A perspective on mechanistic insight and current status
    Niharika Singh, Puja Panwar Hazari, Parul Mittal, Shiv Kumar Yadav, Nitin Kumar, Gauri Mishra, Saurabh Dahiya, Anil Kumar Mishra · 2025 · European Journal of Pharmacology
  23. Serotonergic Regulation in Alzheimer’s Disease
    Л. П. Долгачева, В. П. Зинченко, Alexander D. Nadeev, Nikolay V. Goncharov · 2025 · International Journal of Molecular Sciences
  24. Presynaptic 5-HT2A-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis
    Alice Taddeucci, Guendalina Olivero, Alessandra Roggeri, Claudio Milanese, Francesco Paolo Di Giorgio, Massimo Grilli, Mario Marchi, Beatrice Garrone, Anna Pittaluga · 2022 · Cells
  25. Molecular and Medical Aspects of Psychedelics
    Adam Wojtas, Krystyna Gołembiowska · 2023 · International Journal of Molecular Sciences
  26. Electrophysiology of 5-HT6 Receptors
    Annalisa Tassone, Graziella Madeo, Giuseppe Sciamanna, Antonio Pisani, Paola Bonsi · 2010 · International review of neurobiology
  27. Psychobiology of Drug-Induced Religious Experience: From the Brain “Locus of Religion” to Cognitive Unbinding
    Paolo Nencini, Kathleen A. Grant · 2010 · Substance Use & Misuse
  28. From neural to genetic substrates of panic disorder: Insights from human and mouse studies
    Mónica Santos, Davide D’Amico, Mara Dierssen · 2015 · European Journal of Pharmacology
  29. Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation
    Gavin P. Schmitz, Yi-Ting Chiu, Mia L. Foglesong, Sarah N. Magee, Martin MacKinnon, Gabriele Maria König, Evi Kostenis, Li-Ming Hsu, Yen-Yu I. Shih, Bryan L. Roth et al. · 2025 · Translational Psychiatry
  30. Hallucinogens in Drug Discrimination
    Lisa E. Baker · 2017 · Current topics in behavioral neurosciences
  31. Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations
    Pavel A. Puzerey, Michael John Decker, Roberto F. Galán · 2014 · Journal of Neurophysiology
  32. Effects of Hallucinogens on Neuronal Activity
    Laia Lladó-Pelfort, Pau Celada, Maurizio S. Riga, Eva Troyano‐Rodriguez, Noemí Santana, Francesc Artigas · 2017 · Current topics in behavioral neurosciences
  33. Cellular rules underlying psychedelic control of prefrontal pyramidal neurons
    Tyler G. Ekins, Isla A. W. Brooks, Sameer Kailasa, Chloe Rybicki-Kler, Izabela Jedrasiak‐Cape, Ethan Donoho, George A. Mashour, Jason C. Rech, Omar J. Ahmed · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  34. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies
    Gill, Hartej, Puramat, Parnian, Patel, Pankti, Gill, Barjot, Marks, CéAnn A., Rodrigues, Nelson B., Castle, David, Cha, Danielle S., Mansur, Rodrigo B., Rosenblat, Joshua Daniel et al. · 2022 · Psychiatry Research
  35. Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
    Nataliya S. Vorobyeva, Alena A. Kozlova · 2022 · Frontiers in Pharmacology
  36. The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder
    Riccardo Guglielmo, Gregor Hasler · 2022 · Neuroscience & Biobehavioral Reviews
  37. Using melanopsin to study G protein signaling in cortical neurons
    Kelly M. McGregor, Carine Bécamel, Philippe Marin, Rodrigo Andrade · 2016 · Journal of Neurophysiology
  38. Electrophysiology of Serotonin Receptors
    Gerard J. Marek · 2010 · Handbook of behavioral neuroscience
  39. 5-HT2A Receptors and BDNF Regulation: Implications for Psychopathology
    Minal Jaggar, Vidita A. Vaidya · 2018 · Springer eBooks
  40. Cortical influences of serotonin and glutamate on layer V pyramidal neurons
    Gerard J. Marek, Darryle D. Schoepp · 2021 · Progress in brain research
  41. Early postnatal stress and neural circuit underlying emotional regulation.
    M. Matsumoto, M. Yoshioka, H. Togashi · 2009 · International review of neurobiology
  42. Novelty-induced activity-regulated cytoskeletal-associated protein (Arc) expression in frontal cortex requires serotonin 2A receptor activation
    Martin A. Santini, Anders Bue Klein, M. El-Sayed, Cecilia Ratner, Gitte M. Knudsen, Jens Damsgaard Mikkelsen, Susana Aznar · 2011 · Neuroscience
  43. Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N -Dimethyltryptamine in Rats
    Nicolas G. Glynos, Emma R. Huels, Trent Groenhout, Abhinav Raghu, Amanda G. Nelson, Youngsoo Kim, Abdallah M. Zeid, Tiecheng Liu, George A. Mashour, Robert T. Kennedy et al. · 2025 · Journal of Neuroscience
  44. Psychedelic compounds directly excite 5-HT 2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT 2A Gq -mediated activation mechanism
    Gavin P. Schmitz, Yi-Ting Chiu, Gabriele Maria König, Evi Kostenis, Bryan L. Roth, Melissa A. Herman · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Untitled work
    Barnett · 2024 · 10.1089/psymed.2023.0010
  46. G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics
    Gavin P. Schmitz, Bryan L. Roth · 2023 · American Journal of Physiology-Cell Physiology
  47. A potential role for psilocybin in the treatment of obsessive-compulsive disorder
    Edward Jacobs · 2020 · Journal of Psychedelic Studies
  48. Psychedelic neuroplasticity of cortical neurons lacking 5-HT2A receptors
    Tyler G. Ekins, Chloe Rybicki-Kler, Tao Deng, Isla A. W. Brooks, Izabela Jedrasiak‐Cape, Ethan Donoho, Omar J. Ahmed · 2025 · Molecular Psychiatry
  49. HTR2 Receptors in a Songbird Premotor Cortical-Like Area Modulate Spectral Characteristics of Zebra Finch Song
    W. Wood, Thomas K. Roseberry, D. J. Perkel · 2013 · Journal of Neuroscience
  50. Cellular Effects of Serotonin in the CNS
    Rodrigo Andrade, Sheryl G. Beck · 2010 · Handbook of behavioral neuroscience
  51. Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure
    Mona El-Sayed Hervig, Nadja Cecilie Hvid Jensen, Nadja Bredo Rasmussen, Rasmus Rydbirk, Mikkel Vestergaard Olesen, Anders Hay‐Schmidt, Bente Pakkenberg, Susana Aznar · 2017 · Behavioural Brain Research
  52. Assessing potential of psilocybin for depressive disorders
    Kozak, Zofia, Johnson, Matthew W., Aaronson, Scott T. · 2023 · Expert Opinion on Investigational Drugs
  53. A continuum hypothesis of psychotomimetic rapid antidepressants
    Joost Haarsma, Catherine J. Harmer, Sandra Tamm · 2021 · Brain and Neuroscience Advances
  54. The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex
    Michelle M. Menezes, Martin A. Santini, Mark J. Benvenga, Gerard J. Marek, Kalpana Merchant, Jens Damsgaard Mikkelsen, Kjell A. Svensson · 2013 · Neuroscience Journal
  55. A Cost-Effective Method for Preparing, Maintaining, and Transfecting Neurons in Organotypic Slices
    Cary Soares, Kevin F. H. Lee, Denise Cook, Jean-Claude Béïque · 2014 · Methods in molecular biology
  56. A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder
    Seon‐Cheol Park, Yong‐Ku Kim · 2018 · Psychiatry Investigation
  57. Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS)
    James R. Austgen, David D. Kline · 2013 · Brain Research
  58. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT2A receptor agonist DOI
    Martin A. Santini, Darrick T. Balu, Matthew D. Puhl, Tiffany E. Hill‐Smith, Alexandra Berg, Irwin Lucki, Jens Damsgaard Mikkelsen, Joseph T. Coyle · 2013 · Behavioural Brain Research
  59. Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine
    Gerard J. Marek · 2008 · European Neuropsychopharmacology
  60. Intra- and Interhemispheric Propagation of Electrophysiological Synchronous Activity and Its Modulation by Serotonin in the Cingulate Cortex of Juvenile Mice
    Víctor Rovira, Emilio Geijo‐Barrientos · 2016 · PLoS ONE
  61. Enduring Loss of Serotonergic Control of Orbitofrontal Cortex Function Following Contingent and Noncontingent Cocaine Exposure
    A. Wright, Agustín G. Zapata, Michael H. Baumann, Joshua S. Elmore, Alexander F. Hoffman, Carl R. Lupica · 2016 · Cerebral Cortex
  62. Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction
    Marta L.C. Palhas, Rémi Corne, Raymond Mongeau · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  63. Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats
    Karolina Noworyta, Katarzyna Kamińska, Joanna Rzemieniec, Agnieszka Wnuk, Jakub Wojcieszak, Anna Maria Górska, Grzegorz Kreiner, Małgorzata Kajta, Krystyna Gołembiowska · 2018 · Forensic Toxicology
  64. The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex
    Zi-Hang Tang, Zhipeng Yu, Qiong Li, Xiaoqin Zhang, Kadeliya Muhetaer, Zhengchun Wang, Peng Xu, Haowei Shen · 2023 · Psychopharmacology
  65. The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
    Dongsun Park, Gwangho Lee, Won-Gyu Lee, B.S. Kim, Yoonji Lee, Ji‐Woon Kim · 2025 · Molecular Psychiatry
  66. Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity
    Azat Nasretdinov, Sebastián A. Barrientos, Ivani Brys, Pär Halje, Per Petersson · 2023 · Frontiers in Neuroscience
  67. Stress-induced hyperthermia, the serotonin system and anxiety
    Christiaan H. Vinkers, Berend Olivier, J. Adriaan Bouwknecht, Lucianne Groenink, Olivier, J.D.A. · 2010 · Radboud Repository (Radboud University)
  68. HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
    Terrell D. Holloway, José L. Moreno, Javier González‐Maeso · 2016 · Journal of Visualized Experiments
  69. Utilisation des psychédéliques en psychiatrie : lien avec les neurotrophines
    Rémi Corne, Raymond Mongeau · 2019 · Biologie Aujourd hui
  70. Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects
    Adam J. Drewko, Ron L. P. Habets, Tibor M. Brunt · 2025 · Molecular Psychiatry
  71. Whole Cell Recording from an Organotypic Slice Preparation of Neocortex
    Robert C. Foehring, Dongxu Guan, Tara Toleman, Angela R. Cantrell · 2011 · Journal of Visualized Experiments
  72. Release of a single neurotransmitter from an identified interneuron coherently affects motor output on multiple time scales
    Andrew M. Dacks, Klaudiusz R. Weiss · 2013 · Journal of Neurophysiology
  73. Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21–25, 2008: The rapporteur reports
    Roohi Abubaker, Maaike Alaerts, Ava-Ann Allman, Jennifer H. Barnett, Pauline Belujon, Robert A. Bittner, Thomas H.J. Burne, Wiepke Cahn, Steven Andrew Chance, Sara Cherkerzian et al. · 2008 · Schizophrenia Research
  74. Hallucinogens
    James B. Hanks, Javier González‐Maeso · 2016 · Elsevier eBooks
  75. Serotonin neurobiology in cocaine use disorder
    Kathryn A. Cunningham, Leonard Lee Howell, Noelle C. Anastasio · 2020 · Handbook of behavioral neuroscience
  76. Discovery of antidepressant active compounds from Polygala tenuifolia Willd.: An integrated multitarget screening strategy combining network pharmacology with cell membrane chromatography coupled to high performance liquid chromatography
    Minghui Liu, Jiaxin Yin, Rui Sun, Jie Yong, Xiao Han, Wanjiao Wang, Yu Wang, Menglei Song, Tong Wu, Shengli Han et al. · 2025 · Journal of Ethnopharmacology
  77. Serotonergic modulation of excitatory synapse development and plasticity
    Victoria N. Chang, Roberto Ogelman, Raul Satoshi Vargas, Won Chan Oh · 2026 · Molecules and Cells
  78. Electrophysiological mechanisms of psychedelic drugs: A systematic review
    Javier Hidalgo Jiménez, Kristjan Kaup, Jaan Aru · 2026 · Neuroscience & Biobehavioral Reviews
  79. Agitation: Neurobiology and current management guidelines
    Christopher W. T. Miller, Mario Rullo, Sarah Van Remmen, Sara Mahmood · 2024 · The American Journal of Emergency Medicine
  80. Abnormal cell-intrinsic and network excitability in the neocortex of serotonin-deficient Pet-1 knockout mice.
    Pavel A. Puzerey, Nathan X. Kodama, R. F. Galán · 2016 · Journal of Neurophysiology
  81. Animal Models and Hallucinogenic Drugs
    Alexey Kozlenkov, Javier González‐Maeso · 2012 · Springer eBooks
  82. Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI
    Randall J. Olson, Lowell Bartlett, Alex Sonneborn, Russell Milton, Zachary Bretton-Granatoor, Ayesha Firdous, Alexander Z. Harris, Atheir I. Abbas · 2023 · Neuropharmacology
  83. Neurobiologische Grundlagen der Wirkung von Psychedelika
    Franz X. Vollenweider, Katrin H. Preller · 2017 · Springer eBooks
  84. Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives – A Computational Study
    2022 · Letters in Applied NanoBioScience
  85. Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice
    Christopher W. Thomas, Cristina Blanco‐Duque, Benjamin J. B. Bréant, Guy M. Goodwin, Trevor Sharp, David M. Bannerman, Vladyslav V. Vyazovskiy · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Robust Methods For Quantifying Neuronal Morphology And Molecular Signaling Reveal That Psychedelics Do Not Induce Neuroplasticity
    Umed Boltaev, Hyun W. Park, Keaon R. Brown, Maya Delgado, Jorryn Wu, Brianna N. Diaz-Pacheco, Maria Botero-Pinzon, Keer He, Erin Ahern, Nina Goldshmid et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Absence of sex differences in serotonergic control of orbitofrontal cortex neuronal activity
    Kailin Mooney, Alexander F. Hoffman, Carl R. Lupica · 2025 · Scientific Reports
  88. Serotonin-endocannabinoid crosstalk selectively regulates inhibitory GABAergic inputs in the medial prefrontal cortex
    Rodrigo C. Meza, Koyam Morales-Weil, Carlos Ancatén-González, Angélica P. Escobar, Alejandro Alcaino, Nicole K. Sanguinetti, Eric J. Delpire, Pablo R. Moya, Chiayu Q. Chiu, Marco Fuenzalida et al. · 2026 · Neuropsychopharmacology
  89. Common and contrasting effects of 5-HTergic signaling in pyramidal cells and SOM interneurons of the mouse cortex
    Nathalie Schmitz, Sadat Hodzic, Therese Riedemann · 2024 · Neuropsychopharmacology
  90. Serotonergic Modulation of Spontaneous and Evoked Transmitter Release in Layer II Pyramidal Cells of Rat Somatosensory Cortex
    Fransiscus Adrian Agahari, Christian Stricker · 2020 · Cerebral Cortex
  91. Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2
    Lena M. Rudy, Michał M. Godlewski · 2025 · International Journal of Molecular Sciences
  92. Hallucinogens
    Ryan H.A. Chan, John E. Mendelson · 2014 · Elsevier eBooks
  93. Cellular effects of serotonin in the CNS
    Rodrigo Andrade, Samir Haj‐Dahmane · 2020 · Handbook of behavioral neuroscience
  94. Psychedelic‐Induced Experiences
    James Fadiman, Andrew Kornfeld · 2013 · Wiley eBooks
  95. The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis
    Jia-Ru Li, Kuo-Tung Chiang, Yu‐Chen Kao, Chia‐Ling Yu, Fu‐Chi Yang, Chih‐Sung Liang, Tien‐Wei Hsu · 2024 · Journal of Affective Disorders
  96. Modulation by serotonin reveals preferred recurrent excitatory connectivity in layer II of rat neocortex
    Fransiscus Adrian Agahari, Christian Stricker · 2025 · Cerebral Cortex
  97. Transcriptomically-Guided Pharmacological Experiments in Neocortical and Hippocampal NPY-Positive GABAergic Interneurons
    Sanne Beerens, Jochen Winterer, David Lukacsovich, Csaba Földy, Christian Wozny · 2022 · Zurich Open Repository and Archive (University of Zurich)
  98. Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment
    José L. Moreno, Javier González‐Maeso · 2018 · Springer eBooks
  99. Seeing Snakes
    G. T. Roche · 2010
  100. Novel Targets for Drug Treatment in Psychiatry
    Mitsumasa Kurita, Aintzane García‐Bea, Javier González‐Maeso · 2016 · Springer eBooks